SABBY Management, LLC, 10% Owner at Celsus Therapeutics Plc. (CLTX), bought 68,404 shares at $6.00 ($383K) on 2014-04-04, disclosed to the SEC on 2014-04-08.
Open-market purchase of $383k CLTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 1,000 | $6K | 1.6% |
| 2 | $6.08 | 11,250 | $68K | 17.9% |
| 3 | $5.64 | 16,900 | $95K | 24.9% |
| 4 | $6.00 | 3,754 | $23K | 5.9% |
| 5 | $5.36 | 35,500 | $190K | 49.7% |
| Total | $5.59 avg | 68,404 |
| $383K |
| 100% |
| Filing → |
| VLCN | BUY | 2024-08-28 | $5K | — | Filing → |
| VLCN | BUY | 2024-08-26 | $11K | — | Filing → |
| VLCN | SELL | 2024-08-26 | $134K | — | Filing → |